KIMBERLEY PRIVETT: Open Payments
NPI 1720337967 · FLEMINGSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,324 in 64 payments from 9 companies in 2025. Trend: 2023 $1,361 · 2024 $1,900 · 2025 $1,324
Food & beverage: $1,324
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $403 |
| Amgen Inc. | 17 | $345 |
| Neurocrine BioSciences, Inc. | 7 | $180 |
| MERZ NORTH AMERICA, INC. | 1 | $142 |
| Lilly USA, LLC | 5 | $96 |
| AstraZeneca Pharmaceuticals LP | 1 | $70 |
| PFIZER INC. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Ardelyx, Inc. | 1 | $19 |
Products named: OTEZLA, VRAYLAR, INGREZZA, QULIPTA, REPATHA, AIRSUPRA, ZEPBOUND, PAXLOVID.
Industry payments across KY — which companies pay providers there.
